Simultaneous Determination Of D-Amino Acids In Rat Urine By High-Performance Liquid Chromatography-Tandem Mass Spectrometry Meth-Od: Application To Investigate The Clinical Value Of D-Amino Acids In The Early Diagnosis Of Alzheimer'S Disease

Min Zhang,Shuting Zhang,Weichao Yu,Xiaoyan Li,Ning Ma,Yan Cui
DOI: https://doi.org/10.2174/1573412916999200717235048
2021-01-01
Current Pharmaceutical Analysis
Abstract:Background: D-amino acids are closely related to the development and progression of Alzheimer's disease (AD) and are expected as the novel biomarkers for AD diagnosis.Objective: The aim was to investigate the potential clinical value of D-amino acids for Alzheimer's disease.Methods: A simple and sensitive HPLC/MS-MS method was developed for the simultaneous determination of D-alanine, D-glutamine, D-proline and D-serine in rat urine. The samples were firstly pretreated by methanol, then derivatized by 7-chloro-4-nitrobenzoxadiazole with Fudosteine as internal standard, enantioseparated on Sumichiral OA-2500S column, using a mobile phase composed of acetonitrile-methanol (50:50, v/v) containing 0.5% formic acid, and detected with 4000 Qtrap MS/MS in electrospray-ionization source by negative ion mode.Results: The established method was successfully applied to determine the D-amino acid levels in rat urine from 20 Alzheimer's disease rats and 20 age-matched normal controls. The mean levels of D amino acids in the urine of Alzheimer's disease rats were all significantly lower than those in normal controls. Based on the contents of D-amino acids, the distinction model between Alzheimer's disease rats and normal controls was established by the Bayesian discriminant analysis.Conclusion: The relationship between Alzheimer's disease and D-amino acids revealed that D-amino acids would be potential biomarkers for Alzheimer's disease.
What problem does this paper attempt to address?